Could ketamine ease severe BPD? small trial launches
NCT ID NCT07099534
First seen May 12, 2026 · Last updated Jun 23, 2026 · Updated 8 times
Summary
This pilot study will test whether two intravenous ketamine infusions can quickly reduce symptoms in 38 adults with severe borderline personality disorder. Participants receive the infusions 24 hours apart and are followed for three months. The goal is to see if ketamine, combined with standard care, provides short-term relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BORDERLINE PERSONALITY DISORDER (BPD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Toulouse Purpan University Hospital, Head of Psychiatry Clinic in the UF3 department
Toulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ketamine (given intravenously)
What this could lead to
If it works, this could point toward a fast-acting treatment option for severe BPD symptoms.
What could go wrong
This is a very small pilot study (38 people) with no placebo group, so results may not be reliable. Ketamine can cause side effects like dissociation or nausea.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.